Skip to Content

Notice

Importer of Controlled Substances; Notice of Registration; Cerilliant Corporation

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

By Notice dated September 9, 2013, and published in the Federal Register on September 17, 2013, 78 FR 57176, Cerilliant Corporation, 811 Paloma Drive, Suite A, Round Rock, Texas 78665-2402, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the following basic classes of controlled substances:

DrugSchedule
Cathinone (1235)I
Start Printed Page 1390
Methcathinone (1237)I
Mephedrone (1248)I
N-Ethylamphetamine (1475)I
N,N-Dimethylamphetamine (1480)I
Fenethylline (1503)I
Gamma Hydroxybutyric Acid (2010)I
JWH-018 (7118)I
JWH-073 (7173)I
JWH-200 (7200)I
Alpha-ethyltryptamine (7249)I
Ibogaine (7260)I
CP-47497 (7297)I
CP-47497 C8 Homologue (7298)I
Lysergic acid diethylamide (7315)I
2C-T-7 (7348)I
Marihuana (7360)I
Tetrahydrocannabinols (7370)I
Mescaline (7381)I
3,4,5-Trimethoxyamphetamine (7390)I
4-Bromo-2,5-dimethoxyamphetamine (7391)I
4-Bromo-2,5-dimethoxyphenethylamine (7392)I
4-Methyl-2,5-dimethoxyamphetamine (7395)I
2,5-Dimethoxyamphetamine (7396)I
3,4-Methylenedioxyamphetamine (7400)I
3,4-Methylenedioxy-N-ethylamphetamine (7404)I
3,4-Methylenedioxymethamphetamine (7405)I
4-Methoxyamphetamine (7411)I
5-Methoxy-N-N-dimethyltryptamine (7431)I
Alpha-methyltryptamine (7432)I
Diethyltryptamine (7434)I
Dimethyltryptamine (7435)I
Psilocybin (7437)I
Psilocyn (7438)I
5-Methoxy-N,N-diisopropyltryptamine (7439)I
N-Benzylpiperazine (7493)I
MDPV (7535)I
Methylone (7540)I
Desomorphine (9055)I
Etorphine (except HCl)(9056)I
Heroin (9200)I
Morphine-N-oxide (9307)I
Normorphine (9313)I
Pholcodine (9314)I
Dextromoramide (9613)I
Dipipanone (9622)I
Racemoramide (9645)I
Trimeperidine (9646)I
1-Methyl-4-phenyl-4-propionoxypiperidine (9661)I
Tilidine (9750)I
Amphetamine (1100)II
Methamphetamine (1105)II
Methylphenidate (1724)II
Amobarbital (2125)II
Pentobarbital (2270)II
Secobarbital (2315)II
Phencyclidine (7471)II
Phenylacetone (8501)II
Cocaine (9041)II
Codeine (9050)II
Dihydrocodeine (9120)II
Oxycodone (9143)II
Hydromorphone (9150)II
Ecgonine (9180)II
Ethylmorphine (9190)II
Meperidine (9230)II
Methadone (9250)II
Dextropropoxyphene, bulk (9273)II
Morphine (9300)II
Oripavine (9330)II
Thebaine (9333)II
Levo-alphacetylmethadol (9648)II
Oxymorphone (9652)II
Poppy Straw Concentrate (9670)II
Alfentanil (9737)II
Sufentanil (9740)II
Fentanyl (9801)II

The company plans to import small quantities of the listed controlled substances for the manufacture of analytical reference standards.

In reference to drug codes 7360 and 7370, the company plans to import a synthetic cannabidiol and a synthetic tetrahydrocannabinol. No other activities for these drug codes are authorized for this registration.

Comments and requests for hearings on applications to import narcotic raw material are not appropriate. 72 FR 3417(2007)

DEA has considered the factors in 21 U.S.C. 823(a) and 952(a) and determined that the registration of Cerilliant Corporation to import the basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. DEA has investigated Cerilliant Corporation to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above named company is granted registration as an importer of the basic classes of controlled substances listed.

Start Signature

Dated: December 23, 2013.

Joseph T. Rannazzisi,

Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

End Signature End Preamble

[FR Doc. 2014-00057 Filed 1-7-14; 8:45 am]

BILLING CODE 4410-09-P